Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Verve Therapeutics Q4 EPS USD -0.69

Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 5.143
million.
* Q4 net income USD -48.353 million
* Q4 EPS USD -0.69

Recent news on Verve Therapeutics

See all news